Cantitate/Preț
Produs

Comparative Genomics and Proteomics in Drug Discovery: Vol 58

Editat de John Parrington, Kevin Coward
en Limba Engleză Hardback – 9 noi 2006
Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 36814 lei  6-8 săpt.
  CRC Press – 5 sep 2019 36814 lei  6-8 săpt.
Hardback (1) 100847 lei  6-8 săpt.
  CRC Press – 9 noi 2006 100847 lei  6-8 săpt.

Preț: 100847 lei

Preț vechi: 136629 lei
-26% Nou

Puncte Express: 1513

Preț estimativ în valută:
19301 20361$ 16084£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780415396530
ISBN-10: 0415396530
Pagini: 164
Ilustrații: 27 b/w images and 27 line drawings
Dimensiuni: 156 x 234 x 17 mm
Greutate: 0.43 kg
Ediția:1
Editura: CRC Press
Colecția Taylor & Francis

Public țintă

Professional Practice & Development

Cuprins

 1. Comparative Genomics and Drug Discovery in Trypanosomatids  2. The Practical Implications of Comparative Kinetoplastid Genomics  3. The Relevance of Host Genes in Malaria  4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics  5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach  6. 'Omics' in Translational Medicine : Are They Lost in Translation?  7. Drug-Target Discovery In Silico : Using the Web to Identify Novel Molecular Targets for Drug Action

Notă biografică

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

Descriere

Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.